Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 4 | Journal for ImmunoTherapy of Cancer

Figure 4

From: MAGE-specific T cells detected directly ex-vivo correlate with complete remission in metastatic breast cancer patients after sequential immune-endocrine therapy

Figure 4

Patient 2 antigen-specific responses post IMQ treatment. Ex-vivo analysis of MAGE and PRAME specific CD8+ (A) and CD4+ (B) T cell responses from bulk PBMCs of Patient 2 by intracellular staining for IFN-γ and TNF-α. CD8+ and CD4+ T cells were bead sorted from PBMCs collected post IMQ treatment and in vitro stimulated with CD8 and CD4 depleted PBMCs pulsed with MAGE, PRAME, SURVIVIN, HER-2, or WT-1 OLPs for 14-21 days. Tumor antigen-specific CD8+ (C) and CD4+ (D) T cell responses were analyzed by intracellular staining for IFN-γ and TNF-α. As controls, T cells were also stimulated with MOG and CEF OLPs and PMA/Ionomycin.

Back to article page